DW
Dogwood Therapeutics, Inc.
DWTX · NASDAQ
$1.46 +2.10% (+$0.03)
1M -36.24%
Market Cap $48.1M
P/E Ratio -
Div. Yield -
ROE 47.85%
Bulios Fair Price
$0.99
32.2% downside
Current Price
$1.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DWTX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.70x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 117.03%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 47.85%
ROA 44.77%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.89x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
3 /100
Unstable EPS volatility 85.33%
Profitable years 0
Beta 1.83x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DWTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gregory Duncan
Employees
8
Headquarters
Alpharetta
Upcoming events
05 NOV
Earnings
Upcoming earnings report